• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ASAHI KASEI MEDICAL CO., LTD. PLASMAFLO OP; PLASMA SEPARATOR, PRODUCT CODE: MDP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ASAHI KASEI MEDICAL CO., LTD. PLASMAFLO OP; PLASMA SEPARATOR, PRODUCT CODE: MDP Back to Search Results
Model Number OP-08W(L)
Device Problem Biocompatibility (2886)
Patient Problem Low Blood Pressure/ Hypotension (1914)
Event Date 11/26/2019
Event Type  Injury  
Manufacturer Narrative
The used device has not been analyzed since it could not be obtained from the customer.In addition, we could not investigate manufacturing and quality control records based on the lot number since it is unknown.The event is considered an allergic reaction and the customer commented that the patient could only be triggered by eating a ham, butter and cheese sandwich a few minutes before the development of pruritus on (b)(6).The treatment method will be changed to immuno-adsorption from the next treatment.We considered that this incident serious since the patient's systolic blood pressure dropped to 70 mmhg, and that the causal relationship could not be denied since the symptom appeared during treatment.Hypotonia is described in warning of the instructions for use as "monitor the patient constantly during treatment with the plasmaflo op.In the event of any of the following (hypotonia) during treatment, immediately ensure the safety of the patient and take appropriate measures in accordance with the directions of the responsible physician.We will continue to monitor similar complaints carefully.
 
Event Description
The patient's primary disease is hypercholesterolemia due to a homozygous variant of ldl cholesterol, which has been treated with ldl apheresis since she was (b)(6) years old.The facility has been implementing the double filtration plasmapheresis for the patient since 2015.On (b)(6) 2019, the patient was treated with plasmaflo op-08w(l) and cascadeflo ec.She suffered from pruritus, especially on the scalp 120 minutes after the start of treatment.The pruritus was associated with infiltrated macular rash located in the hair, the forehead, the cheeks and the neck.These symptoms were associated with a tingling sensation, followed by noticeable angioedema on both the lips and tongue without dyspnea and bronchospasm.The ige value was 336 ui / l, and tryptase was normal both at the time of the event and 30 minutes after the event.Compared to the previous treatment, there was no change in the treatment protocol.The patient's medication did not change, either.These events were treated with polaramine and adrenaline.The ldl treatment has been stopped and the patient stayed the whole day at the hospital for follow-up.Since the symptoms did not recur, cetirizine was prescribed at 10 mg/day for 10 days and she went back home.On (b)(6) 2019, the patient was treated with plasmaflo op-08w(l) and cascadeflo ec.75 minutes after the start of treatment, she suffered from facial and chest erythroses, pruritus, followed by hives and tongue angioedema and then the treatment was discontinued.The ige value was 369 ui / l, and the tryptase value was normal.On (b)(6) 2019, the patient was treated with plasmaflo op-08w(l) and rheofilter er.Cascadeflo ec was changed to rheofilter er and the patient was pre-administered with polaramine before treatment.90 minutes after the start of treatment, rash occurred and systolic blood pressure dropped to 70 mmhg, therefore treatment was discontinued.Plasmaflo op-08w(l) is a plasma separator which is similar product of plasmaflo op-05w(a) marketed in us.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PLASMAFLO OP
Type of Device
PLASMA SEPARATOR, PRODUCT CODE: MDP
Manufacturer (Section D)
ASAHI KASEI MEDICAL CO., LTD.
1-1-2 yurakucho
chiyoda-ku
tokyo, 100-0 006
JA  100-0006
Manufacturer (Section G)
ASAHI KASEI MEDICAL MT CORP. OITA WORKS
2111-2 oaza sato
oita-shi
oita, 870-0 396
JA   870-0396
Manufacturer Contact
akitake yamashita
1-1-2 yurakucho
chiyoda-ku
tokyo, 100-0-006
JA   100-0006
MDR Report Key9514577
MDR Text Key181582590
Report Number8010002-2019-00150
Device Sequence Number1
Product Code MDP
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P820033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 12/05/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/24/2019
Is this an Adverse Event Report? Yes
Device Operator Health Professional
Device Model NumberOP-08W(L)
Device Catalogue NumberN/A
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/05/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age24 YR
Patient Weight59
-
-